“I am tremendously excited about developing contextual models of human disease with the level of functionality previously only found in primary rodent cultures.” -Dr. Myles Fennell
Branford, CT (PRWEB) May 11, 2011
GigaCyte, LLC., a leading provider of human stem cell-based products and preclinical contract research services, headquartered in Branford, Connecticut USA, announced the launch of human hippocampal stem cells for use in neuroscience and cytotoxicity testing. GigaCyte’s hippocampal stem cells have been extensively characterized for neural stem cell and mature neural markers. This unique human organ-derived product differentiates into functionally mature neurons, astrocytes and oligodendrocytes, with neurons displaying abundant and mature excitatory and inhibitory synapses. GigaCyte’s neural progenitors coupled with their proprietary growth medium enables expansion to a scale for high-throughput screening in 384 well cell culture plates with expansion from a reliable and characterized starting bank.
GigaCyte’s Neuroscience Division is led by Myles Fennell, Ph.D. (formerly of Bristol Myers-Squibb and Wyeth) who has led the characterization and validation of our neuronal models and for establishing disease relevant neuroscience assays and collaborations.
“Dr. Fennell’s extraordinary expertise in Neuroscience and High-Content Screening is helping GigaCyte to develop relevant models of disease and develop industry leading image based High-Content endpoints. We are extremely excited to have Myles joining our rapidly growing team,” said Shiloh Barfield, EVP/General Manager of GigaCyte LLC.
“I am tremendously excited about working with the great team of scientists at GigaCyte and developing contextual models of human disease with the level of functionality previously only found in primary rodent cultures.” said Dr. Myles Fennell – Scientific Affairs – Neuroscience of GigaCyte LLC.
About Shiloh Barfield.
Mr. Barfield, was the Vice President of Sales & Marketing for the former venture capital based CellzDirect Inc., (the world’s leader for many years in hepatic drug development services and cell products which was purchased by Invitrogen, Inc. in February 2008 for $57M USD.
About Dr. Myles Fennell
Dr. Fennell is a distinguished scientist and recognized thought leader in the Neuroscience and High-Content screening field. Over the last decade he has established a leadership position in contextual models of neurodegenerative diseases, High-Content analysis and genomic technologies.
About GigaCyte LLC.
GigaCyte, LLC. is a privately held bioscience company that provides bio/pharmaceutical companies and research centers with innovative stem-cell tools, cell culture media and contract laboratory services focused primarily on basic research, drug discovery and preclinical development efforts. For additional information, please refer to the company's web site at http://www.gigacyte.com or email us at sales(at)gigacyte(dot)com or call us at 1-855-544-4229.